Skip to content
MedsAcross

Medicine

Cortrosyn 0.25 mg/mL powder for injection

Cosyntropin · Intramuscular, intravenous · Amphastar Pharmaceuticals
Available on requestPrescription onlyUS FDA

Cortrosyn 0.25 mg/mL powder for injection is a prescription medicine containing Cosyntropin for intramuscular, intravenous use, marketed by Amphastar Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20º to 25ºC (68º to 77ºF), excursions permitted between 15° to 30°C…

Key facts

Active ingredient (INN)
Cosyntropin
Brand
Cortrosyn
Strength
0.25 mg/mL
Dosage form
Powder for injection
Route
Intramuscular, intravenous
Packs
10 vials, 1 vial
Marketing authorisation holder
Amphastar Pharmaceuticals
Manufacturers
Amphastar PharmaceuticalsMedical Purchasing Solutions
Origin register
US FDA, United States
Storage
Store at 20º to 25ºC (68º to 77ºF), excursions permitted between 15° to 30°C (59° to 86°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
H01AA02 Cosyntropin
HS code (indicative)
3004.39Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
1 August 2003
Identifiers
DailyMed set ID 746856e9-3930-4f6a-b8e6-a03845d6dd0b, 15eaaab2-d656-7310-e063-6394a90ae59fNDC 0548-5900, 71872-7318Application NDA016750

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
10 vial in 1 carton / 1 mL in 1 vial0548-5900-00Amphastar Pharmaceuticals1 August 2003
1 vial in 1 bag / 1 mL in 1 vial71872-7318-1Medical Purchasing Solutions1 January 2024

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 22 April 1970Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Alternatives

Other makers and brands of Cosyntropin 0.25 mg/mL powder for injection.

Compare all 2

Clinical summary

Cosyntropin is an adrenocorticotropic hormone indicated , in combination with other diagnostic tests, for use as a diagnostic agent in the screening of adrenocortical insufficiency in adults and pediatric patients. MedsAcross supplies Cosyntropin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Cosyntropin

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Cortrosyn 0.25 mg/mL powder for injection for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.